DrugPatentWatch Database Preview

Polidocanol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for polidocanol and what is the scope of polidocanol patent protection?

Polidocanol is the generic ingredient in two branded drugs marketed by Chemisch Fbrk Krsslr and Provensis, and is included in two NDAs. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for polidocanol

US Patents:	14
Tradenames:	2
Applicants:	2
NDAs:	2
Suppliers / Packagers:	2
Bulk Api Vendors:	29
Clinical Trials:	16
Patent Applications:	1,843
Formulation / Manufacturing:	see details
DailyMed Link:	polidocanol at DailyMed

Pharmacology for polidocanol

Drug Class	Sclerosing Agent
Mechanism of Action	Sclerosing Activity
Physiological Effect	Vascular Sclerosing Activity

Synonyms for polidocanol

2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol

3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol

3055-99-0

9043-30-5

AC1LCVC1

AEO-9

Aethoxy-sklerol

AKOS028108701

AN-6543

API0005051

C12E9

C13493

CAS-3055-99-0

CHEBI:46859

CHEMBL1231723

CTK1C2495

D05ZPL

DB06811

Detergent Screening Solution 23/Fluka kit no 66317

DODECYL NONA ETHYLENE GLYCOL ETHER

Dodecyl nonaethylene glycol ether

Dodecylnonaglycol

Dodecylnonaoxyethylene glycol monoether

DSSTox_CID_19721

DSSTox_GSID_39721

DSSTox_RID_79436

DTXSID5039721

EINECS 221-284-4

genapol X 080

genapol X-080

Genapol X080

GK9185

J-018016

KS-00000Y0K

laureth-9

LP016773

Macrogol 9 lauryl ether

MFCD00043375

MFCD00163738

MolPort-003-935-762

NCGC00166290-01

NCGC00166290-02

NCGC00166290-03

Nonaethylene glycol monododecyl ether

Nonaethylene glycol monododecyl ether, nonionic surfactant

nonaethylene glycol monolauryl ether

Nonaethyleneglycol monododecyl ether 1 mM solution

Nonaethyleneglycol monododecyl ether solution

NONAETHYLENEGLYCOLMONODODECYLETHER

Oligoethylene glycol monoalkyl ether

ONJQDTZCDSESIW-UHFFFAOYSA-N

PEG-9 lauryl ether

POELE

Poly(oxy-1,2-ethanediyl),a-isotridecyl-w-hydroxy-

Polydocanol

Polyethylene glycol 450 lauryl ether

Polyethylene glycol monoalkyl ether

Polyethylene glycol monoisotridecyl ether

Polyoxyethylen-9-laurylether

Polyoxyethylene (9) lauryl ether

Polyoxyethylene 9 lauryl ether

Polyoxyl 9 lauryl ether

SCHEMBL25580

SR-01000944476

SR-01000944476-1

Tox21_112394

Tox21_112394_1

ZINC8214662

US Patents and Regulatory Information for polidocanol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y	Y
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes				Y
Chemisch Fbrk Krsslr	ASCLERA	polidocanol	SOLUTION;INTRAVENOUS	021201-001	Mar 30, 2010		RX	Yes	No
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013		RX	Yes	Yes			Y	Y

Expired US Patents for polidocanol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013
Provensis	VARITHENA	polidocanol	SOLUTION;INTRAVENOUS	205098-001	Nov 25, 2013

International Patents for polidocanol

Country	Document Number	Estimated Expiration
Spain	2254177
Czech Republic	20014007
Japan	2011136192
Denmark	1701701
Australia	2005205772
Australia	2388502